{"id":"https://openalex.org/W4388907475","doi":"https://doi.org/10.1007/s11094-023-02991-1","title":"Stability Indicating RP-HPLC-PDA Method for the Quantification of Solriamfetol in Bulk and Marketed Dosage Form","display_name":"Stability Indicating RP-HPLC-PDA Method for the Quantification of Solriamfetol in Bulk and Marketed Dosage Form","publication_year":2023,"publication_date":"2023-10-01","ids":{"openalex":"https://openalex.org/W4388907475","doi":"https://doi.org/10.1007/s11094-023-02991-1"},"language":"en","primary_location":{"id":"doi:10.1007/s11094-023-02991-1","doi":"https://doi.org/10.1007/s11094-023-02991-1","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11094-023-02991-1","pdf_url":null,"source":{"id":"https://openalex.org/S180695361","display_name":"Pharmaceutical Chemistry Journal","issn_l":"0091-150X","issn":["0091-150X","1573-9031"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Chemistry Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077787865","display_name":"Gowri Gollu","orcid":"https://orcid.org/0000-0002-5203-7839","observed_orcids":["https://orcid.org/0000-0002-5203-7839"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Gowri Gollu","raw_affiliation_strings":["Department of Pharmaceutical Analysis, Raghu College of Pharmacy, Dakamarri, Visakhapatnam, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Analysis, Raghu College of Pharmacy, Dakamarri, Visakhapatnam, Andhra Pradesh, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010414367","display_name":"Sowjanya Gummadi","orcid":"https://orcid.org/0000-0002-5561-6502","observed_orcids":["https://orcid.org/0000-0002-5561-6502"]},"institutions":[{"id":"https://openalex.org/I885392262","display_name":"GITAM University","ror":"https://ror.org/0440p1d37","country_code":"IN","type":"education","lineage":["https://openalex.org/I885392262"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sowjanya Gummadi","raw_affiliation_strings":["Department of Pharmaceutical Analysis, GITAM Institute of Pharmacy, GITAM (Deemed to be university), Visakhapatnam, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Analysis, GITAM Institute of Pharmacy, GITAM (Deemed to be university), Visakhapatnam, Andhra Pradesh, India","institution_ids":["https://openalex.org/I885392262"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5093316993","display_name":"Lekya Gurijala","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lekya Gurijala","raw_affiliation_strings":["Department of Pharmaceutical Analysis, Maharajah\u2019s College of Pharmacy, Phool Baugh, Vizianagaram, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Analysis, Maharajah\u2019s College of Pharmacy, Phool Baugh, Vizianagaram, Andhra Pradesh, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5077787865"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1918,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.31153008,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"57","issue":"7","first_page":"1111","last_page":"1117"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/solriamfetol","display_name":"solriamfetol","score":0.9919999837875366},{"id":"https://openalex.org/keywords/stability-indicating-method","display_name":"stability-indicating assay","score":0.828000009059906},{"id":"https://openalex.org/keywords/rp-hplc-method-development","display_name":"RP-HPLC method development","score":0.8029999732971191},{"id":"https://openalex.org/keywords/stress-degradation","display_name":"stress degradation","score":0.7210000157356262},{"id":"https://openalex.org/keywords/dosage-forms","display_name":"pharmaceutical dosage forms","score":0.6869999766349792},{"id":"https://openalex.org/keywords/quality-control","display_name":"quality control","score":0.8080000281333923},{"id":"https://openalex.org/keywords/narcolepsy-treatment","display_name":"narcolepsy treatment","score":0.6430000066757202},{"id":"https://openalex.org/keywords/drug-quantification","display_name":"pharmaceutical analysis","score":0.6480000019073486}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.863998532295227},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.7792344093322754},{"id":"https://openalex.org/C2777379063","wikidata":"https://www.wikidata.org/wiki/Q161233","display_name":"Formic acid","level":2,"score":0.7114946842193604},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.6816216707229614},{"id":"https://openalex.org/C2777463227","wikidata":"https://www.wikidata.org/wiki/Q408047","display_name":"Acetonitrile","level":2,"score":0.6439345479011536},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.5975764393806458},{"id":"https://openalex.org/C2779679103","wikidata":"https://www.wikidata.org/wiki/Q5251805","display_name":"Degradation (telecommunications)","level":2,"score":0.5807865262031555},{"id":"https://openalex.org/C73826308","wikidata":"https://www.wikidata.org/wiki/Q684907","display_name":"Elution","level":2,"score":0.545541524887085},{"id":"https://openalex.org/C2777682752","wikidata":"https://www.wikidata.org/wiki/Q8564473","display_name":"Forced degradation","level":4,"score":0.49881458282470703},{"id":"https://openalex.org/C2780092901","wikidata":"https://www.wikidata.org/wiki/Q3433612","display_name":"Correlation coefficient","level":2,"score":0.49759963154792786},{"id":"https://openalex.org/C77170095","wikidata":"https://www.wikidata.org/wiki/Q1753188","display_name":"Linearity","level":2,"score":0.4326295852661133},{"id":"https://openalex.org/C113196181","wikidata":"https://www.wikidata.org/wiki/Q485223","display_name":"Analytical Chemistry (journal)","level":2,"score":0.33250153064727783},{"id":"https://openalex.org/C45188465","wikidata":"https://www.wikidata.org/wiki/Q645497","display_name":"Reversed-phase chromatography","level":3,"score":0.22898349165916443},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C76155785","wikidata":"https://www.wikidata.org/wiki/Q418","display_name":"Telecommunications","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/s11094-023-02991-1","doi":"https://doi.org/10.1007/s11094-023-02991-1","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11094-023-02991-1","pdf_url":null,"source":{"id":"https://openalex.org/S180695361","display_name":"Pharmaceutical Chemistry Journal","issn_l":"0091-150X","issn":["0091-150X","1573-9031"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Chemistry Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.46810001134872437}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W2898863714","https://openalex.org/W2928539172","https://openalex.org/W3015427121","https://openalex.org/W3032557605","https://openalex.org/W3172543619","https://openalex.org/W3198716445"],"related_works":["https://openalex.org/W7168282580","https://openalex.org/W4416776629","https://openalex.org/W7220540180","https://openalex.org/W4284972974","https://openalex.org/W7092283279","https://openalex.org/W3040739383","https://openalex.org/W2241846331","https://openalex.org/W3048637499","https://openalex.org/W4200003810","https://openalex.org/W2007420908"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2023-11-23T00:00:00"}